MRD / Regn No. : 20160712003 Date : 22/06/2026
Patient Name : Ganesh Thyagarajan Age & Gender : 54 Yrs. / Male
Contact No. : 9840029448 UHID :
Ht / Wt / BMI : 176.5 / 77.6 / 24.91 BP S / BP D : 142 / 73
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (01/Jan/2008) | OBESITY (02/Jun/2008) | HYPERTENSION (02/Jun/2010) | VITAMIN D DEFICIENCY (02/Jun/2025) | A1G2 DKD (02/Jun/2025) | GU INFECTION WITH SGLT2I (01/Jul/2025) |
Subjective : FATIGUE BETTER,NO URINARY ITCHING
Objective : N
Analysis : TYPE 2 DM,OBESITY,VITAMIN D DEFICIENCY,SGLT2I INDUCED GU ITCHING
Plan : HOLD PIOZ,CONTINUE TIRZEPATIDE 12.5 MG,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : CREATININE: 0.9 mg/dL | FASTING PLASMA GLUCOSE (FPG): 103 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.1 % | POST PRANDIAL GLUCOSE (2HPP): 147 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 32 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 93.60 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 93.60 mL/min/1.73m2 | LDL LOW DENSITY LIPOPROTEIN: 69.2 mg/dL | TGL TRIGLYCERIDE: 84 mg/dL | TOTAL CHOLESTEROL: 118 mg/dl
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJ GLARGINE
TOUJEO
SQ 0-0-18 UNITS AT BEDTIME
TILL NEXT VISIT
2 ROSUVASTATIN 10 MG
CRESTOR 10 MG
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY
3 TELMISARTAN CTD 40 MG
ERITEL CH 40 MG
Medicine For HYPERTENSION KIDNEY PROTECTION
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
4 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
5 INJECTION TIRZEPATIDE 12.5 MG
MOUNJARO
Medicine For OBESITY DIABETES
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING DIARRHEA OR AVERSION TO CERTAIN FOODS
       
Refill : 0 / Substitution:    
Education : LIFESTYLE CHANGES
Next Visit : 21/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: